Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities
2022 · Nature reviews. Cancer · 472 citations
https://doi.org/10.1038/s41568-022-00466-1
D
Daniel P. Hollern
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
3.4K
Citations
21
h-index
29
i10-index
Daniel P. Hollern is an academic researcher from Salk Institute for Biological Studies. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & CAR-T cell therapy research. The author has an h-index of 21, co-authored 88 publications.
ORCID: 0000-0003-0332-5516Papers by this author
worksIntegrated Molecular Characterization of Testicular Germ Cell Tumors
2018 · Cell Reports · 445 citations
https://doi.org/10.1016/j.celrep.2018.05.039
Integrated Molecular Characterization of Testicular Germ Cell Tumors
2018 · Cell Reports · 445 citations
https://doi.org/10.1016/j.celrep.2018.05.039
NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors
2013 · Cell Death and Disease · 204 citations
https://doi.org/10.1038/cddis.2013.82
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer
2020 · Clinical Cancer Research · 50 citations
https://doi.org/10.1158/1078-0432.ccr-20-0389
Loss of function of BRCA1 promotes EMT in mammary tumors through activation of TGFβR2 signaling pathway
2022 · Cell Death and Disease · 23 citations
https://doi.org/10.1038/s41419-022-04646-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat